NCT01291108 - Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension | Biotech Hunter

Enrollment

125

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

October 31, 2011

Study Completion Date

October 31, 2011

Conditions

Glaucoma, Open-AngleOcular Hypertension

Interventions

DRUG

AGN-210669

AGN-210669 0.05% applied as 1 drop in both eyes every evening during Month 1 or Month 2.

DRUG

bimatoprost

bimatoprost ophthalmic solution 0.03% applied as 1 drop in both eyes every evening during Month 1 or Month 2.

DRUG

bimatoprost vehicle

bimatoprost ophthalmic solution 0.03% vehicle applied as 1 drop in both eyes every evening during Month 2.

Trial Locations (1)

Austin